FAQ/Help |
Calendar |
Search |
Today's Posts |
08-14-2014, 10:37 AM | #1 | ||
|
|||
Member
|
Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008A)
http://clinicaltrials.gov/ct2/show/N...&sel_rss=mod14 This is a follow-up study to assess safety and clinical activity of continued AFFITOPE® PD01A vaccinations in patients with Parkinson's disease. Patients, who have already participated in AFF008 will be involved and will be receive one boost immunization with AFFITOPE® PD01A. One study site in Vienna (Austria) will be involved. In addition, up to 8 patients will be offered participation within an untreated control group. |
||
Reply With Quote |
"Thanks for this!" says: | olsen (08-15-2014) |
08-14-2014, 10:57 AM | #2 | ||
|
|||
Member
|
Quote:
|
||
Reply With Quote |
08-14-2014, 11:15 AM | #3 | ||
|
|||
Member
|
It's also invitation only and has no waiting list. "Unless you know somebody"
|
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Feedback regard NeuroScience supplements | Medications & Treatments | |||
MG Follow-Up Study Data | Myasthenia Gravis | |||
Follow-up Study MTA - ADHD Treatments | Attention Deficit Disorder |